Novo Nordisk's Wegovy pill was prescribed more than 18,000 times in the U. in the first full week after its launch in an ...

LIR Life Sciences is a leader in the dvancement of novel, needle-free drug delivery platforms for obesity treatment across ...

A once-weekly injectable glucose-dependent insulinotropic polypeptide/GLP-1 dual agonist conferred up to 14.7% weight loss at ...

In December, Novo Nordisk announced that the Food and Drug Administration had approved its once-daily Wegovy pill, the first oral GLP-1 medicine for obesity in the United States. It remains the only ...

Thailand’s Public Health Ministry is ramping up efforts to combat the rising obesity rates and the broader issue of NCDs ...